Davide Leone & Partners Investment Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$41.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$41.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$79.3M |
| 2 |
NXP Semiconductors
NXPI
|
+$27.2M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$24.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 55.14% |
| 2 | Communication Services | 20.06% |
| 3 | Healthcare | 9.71% |
| 4 | Financials | 0.04% |
Similar funds
Davide Leone & Partners Investment Company's Q3 2018 Portfolio in Review
As of Q3 2018, Davide Leone & Partners Investment Company held 16 positions worth $878M, down 22% from $1.13B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Davide Leone & Partners Investment Company withdrew a net $291M in Q3 2018, closing 6 positions and reducing 1 holding. Its most notable exit was Bristol-Myers Squibb, an estimated $79.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 55% of assets, up from 49% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Davide Leone & Partners Investment Company opened a new position in Incyte worth $42.2M.
- Davide Leone & Partners Investment Company's largest Q3 2018 buy was Incyte: 610,851 shares worth $42.2M.
- Davide Leone & Partners Investment Company's biggest Q3 2018 reduction was NXP Semiconductors, cutting an estimated $27.2M.
- Davide Leone & Partners Investment Company fully exited Bristol-Myers Squibb in Q3 2018, selling an estimated $79.3M.
- Davide Leone & Partners Investment Company's ten largest holdings make up 100% of its $878M portfolio in Q3 2018.
- Davide Leone & Partners Investment Company opened 2 new positions and closed 6 in Q3 2018.
- Davide Leone & Partners Investment Company's portfolio value fell 22% quarter-over-quarter to $878M.
Based on Davide Leone & Partners Investment Company's 13F filing for Q3 2018, filed 14 Nov 2018.